Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Context: Metformin is used in pregnancy in women with gestational diabetes mellitus, polycystic ovary syndrome (PCOS), and obesity. Metformin passes the placenta. Objective: To explore the effects of metformin use in PCOS pregnancies on offspring growth to 4 years of age. Design: Follow-up study of two randomized, double-blind, placebo-controlled trials. Setting: Secondary care centers. Eleven public hospitals in Norway. Participants: One hundred eighty-two children of mothers with PCOS who participated in two randomized controlled trials. Intervention: Metformin 1700 or 2000 mg/d or placebo from first trimester to delivery in the original studies. No intervention in the current study. Main Outcome Measures: Height, weight, body mass index (BMI), and overweight/obesity at 4 years of age and head circumference at 1 year of age, converted to z scores. Results: The difference in height z score means between the groups at 4 years of age was nonsignificant (0.07 [95% confidence interval (CI): -0.22 to 0.36]; P = 0.651). At 4 years of age, the metformin group had higher weight z score than the placebo group [difference in means: 0.38 (0.07 to 0.69); P = 0.017] and higher BMI z score [difference in means: 0.45 (0.11 to 0.78); P = 0.010]. There were more overweight/obese children in the metformin group [26 (32%)] than in the placebo group [14 (18%)] at 4 years of age [odds ratio: 2.17 (1.04 to 4.61); P = 0.038]. The difference in mean head circumference z score at 1 year of age was 0.27 (-0.04 to 0.58; P = 0.093). Conclusion: Metformin-exposed children had higher BMI and increased prevalence of overweight/obesity at 4 years of age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In one RCT of metformin use in pregnancy for polycystic ovary syndrome, follow-up of 4-year-old offspring demonstrated higher BMI and increased obesity in the offspring exposed to metformin (87).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [87]
In the citing paper
“Notably, 2 studies reported that metformin-exposed children of mothers with polycystic ovary syndrome or GDM were found to weigh more at 471 and 9 years of age.72”
From Gestational Diabetes Mellitus (2019) · cites this paper as [71]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Extended international (IOTF) body mass index cut‐offs for thinness, overweight and obesity
Cole, T. J., & Lobstein, T. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00064.x · Cited by 3,117
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Predicting adult obesity from childhood obesity: a systematic review and meta‐analysis
Simmonds, M., Llewellyn, A., Owen, C. G., & Woolacott, N. (2016) · Obesity Reviews · doi:10.1111/obr.12334 · Cited by 2,103
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Childhood obesity as a predictor of morbidity in adulthood: a systematic review and meta‐analysis
Llewellyn, A., Simmonds, M., Owen, C. G., & Woolacott, N. (2016) · Obesity Reviews · doi:10.1111/obr.12316 · Cited by 818
Pregnancy complications in women with polycystic ovary syndrome
Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P. H., La Sala, G. B., & Fauser, B. C. J. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv029 · Cited by 691
Cited by
Items 101–199 of 199
Forcato, S., Montagnini, B. G., de Góes, M. L. M., Novi, D. R. B. S., Kiss, A. C. I., Ceravolo, G. S., & Gerardin, D. C. C. (2019) · Reproductive Toxicology · doi:10.1016/j.reprotox.2019.04.009 · Cited by 11
The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy
Blair, R. A., Rosenberg, E. A., & Palermo, N. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1243-1 · Cited by 10
Treatment of Gestational Diabetes Mellitus and Offspring Early Childhood Growth
Feghali, M. N., Atlass, J., Abebe, K. Z., COMER, D. M., Catov, J. M., Caritis, S. N., Arslanian, S. A., & Scifres, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa742 · Cited by 9
Lovell, H., Mitchell, A., Ovadia, C., Pitrelli, N., Briley, A. L., Singh, C. M., Marschall, H., Cruickshank, K. J., Murphy, H. R., Seed, P. T., et al. (2022) · Trials · doi:10.1186/s13063-022-06462-y · Cited by 11
Prenatal metformin treatment improves ovarian function in offspring of obese rats
Álvarez, D., Ceballo, K., Olguín, S., Martínez-Pinto, J., Maliqueo, M. A., Fernandois, D., Sotomayor‐Zárate, R., & Cruz, G. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0352 · Cited by 9
Gestational Diabetes and Type 2 Diabetes During Pregnancy
Mukerji, G., Bacon, S., & Feig, D. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00022-2 · Cited by 13
Metformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions
González, C. D., Alvariñas, J., Bagnes, M. F. G., & Girolamo, G. D. (2018) · Current Clinical Pharmacology · doi:10.2174/1574884714666181224151116 · Cited by 10
Ryu, K.-J., Wi, W. Y., Nam, S., Jeong, H. G., Cho, G. J., Park, H., & Kim, T. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e111 · Cited by 8
Is metformin safe in pregnancy: a focus on offspring outcomes
Malek, R., & Davis, S. N. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2424410 · Cited by 11
“Based on these results the study authors hypothesized that less overweight/obesity would be seen in metformin exposed offspring [15].”
Grindheim, S., Ebbing, C., Karlsen, H. O., Skulstad, S. M., Real, F. G., Lønnebotn, M., Løvvik, T. S., Vanky, E., & Kessler, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262987 · Cited by 7
Self-citationPolycystic ovary syndrome and miscarriage: a narrative review
Bui, L. M., Aghajanova, L., Lathi, R. B., & Sokalska, A. (2024) · F&S Reviews · doi:10.1016/j.xfnr.2024.100078 · Cited by 6
Cantacorps, L., Zhu, J., Yagoub, S., Coull, B. M., Falck, J. E., Chesters, R., Ritter, K., Serrano-Lope, M. A., Tscherepentschuk, K., Kasch, L.-S., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101860 · Cited by 6
“In addition, studies in pregnant people with polycystic ovary syndrome (PCOS) on metformin therapy have reported an increased body weight and BMI in 6-month-old children which persisted until 4 years of age [22], alongside an increased obesity risk in metformin-exposed children [23].”
BackgroundGreenhill, C. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.34 · Cited by 6
Sun, M., Bai, W., Song, Q., Wang, H., Gao, G., Zheng, L., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.576458 · Cited by 9
Metformin in pregnancy – safe or sorry?
Vanky, E., & Ødegård, R. A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0081-6 · Cited by 6
Self-citationADIPS position paper on pre‐existing diabetes and pregnancy
Rudland, V. L., Price, S., & Callaway, L. K. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13266 · Cited by 6
McCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Zhou, H., Yang, W., Liu, N., Liu, Q., Jin, J., Zhao, C., Jin, X., Gui, M., Zhu, H., Zhang, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202506091 · Cited by 7
Correlates of Insulin Selection as a First-Line Pharmacological Treatment for Gestational Diabetes
Palatnik, A., Harrison, R. K., Thakkar, M. Y., Walker, R. J., & Egede, L. E. (2021) · American Journal of Perinatology · doi:10.1055/s-0041-1739266 · Cited by 5
Insulin and Other Hypoglycemic Drugs
Pittman, J. M., Schalliol, L. A., & Ray, S. D. (2017) · Side effects of drugs annual · doi:10.1016/bs.seda.2017.06.026 · Cited by 7
Quadir, H. (2021) · Cureus · doi:10.7759/cureus.18818 · Cited by 6
Metformin use during pregnancy: Is it really safe?
Paschou, S. Α., & Wolffenbuttel, B. H. R. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12813 · Cited by 5
“addition, metformin use in PCOS pregnancies is associated with a higher risk for the child of being overweight at the age of 4 years.(11) In obese women, metformin had no significant effect on birth weight percentile.”
BackgroundBenhalima, K., Mathiesen, E. R., Paldanius, P. M., & Mathieu, C. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13386 · Cited by 4
“Recent data suggest significantly increased rates of overweight and obesity in a cohort of 4-year-old children of mothers with polycystic ovarian syndrome who were exposed to metformin during pregnancy compared to the offspring of non-exposed women.(8) Women of childbearing age with T2DM are now frequently trea-”
BackgroundRyssdal, M., Skage, J. E., Jarmund, A. H., Hanem, L. G. E., Løvvik, T. S., Giskeødegård, G. F., Iversen, A., & Vanky, E. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18320 · Cited by 5
Self-citationUse of Inositols in Polycystic Ovary Syndrome
Pustotina, O. A. (2020) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2020-16-28-24-34 · Cited by 5
Long-term effects of metformin use in gestational diabetes mellitus on offspring health
Roy, A., & Sahoo, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i11.1812 · Cited by 5
Treatment of Diabetes in Pregnancy With Metformin
Newman, C., & Dunne, F. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005705 · Cited by 5
“At 4 and 10 years after delivery, offspring of individuals with polycystic ovarian syndrome treated with metformin had higher BMI z-scores 26,53 ; higher subcutaneous fat (mid-upper arm circumference, subscapular and bicep skinfold) levels were seen at age 2 years in offspring of women with GDM who…”
Metformin use in gestational diabetes
Campbell, I. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00018-7 · Cited by 3
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1901-0499 · Cited by 3
Nofal, A. A., Benkhadra, K., Abbas, A. S., Nduwimana, M.-J., Al-Kordi, M., Allababidi, A. K., Wyckoff, J., Lapolla, A., Prokop, L. J., Wang, Z., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf289 · Cited by 3
AMPK function in uterine vasculature and placenta at high altitude
Lorca, R. A. (2025) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0174 · Cited by 3
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1946-3648 · Cited by 3
Reproductive outcomes in female mice offspring due to maternal metformin treatment
Velázquez, C., Herrero, Y., Prost, K., Bordaquievich, M., Neira, M., Parborell, F., & Abramovich, D. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123416 · Cited by 2
Is metformin effective and safe during pregnancy in women with PCOS? An overview of reviews
Palomba, S., Seminara, G., Costanzi, F., Sculli, M. A., Alessi, E., Caserta, D., & Aversa, A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2574334 · Cited by 7
Metformin therapy in pregnancy [Zastosowanie metforminy w ciąży]
Krupej, J., Cichocka, E., Kędzierski, L., Okopień, B., & Gumprecht, J. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0016 · Cited by 2
Biagioni, E. M., ROWE, J. C., Yendamuri, S., Wisseman, B., Zheng, D., Zhang, G., Muoio, D. M., DeVente, J., Fisher‐Wellman, K. H., Neufer, P. D., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00428.2024 · Cited by 2
Liu, D., Chen, X., Wang, Q., Pan, X., Wei, X., Wang, B., Wang, Y., Xue, X., & Lu, C. (2025) · Precision medication. · doi:10.1016/j.prmedi.2025.100035 · Cited by 3
Nordtvedt, E., Kessler, J., Ebbing, C., Acharya, G., Løvvik, T. S., Salvesen, K. Å., Salvesen, Ø. O., Vanky, E., & Kahrs, B. H. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07866-9 · Cited by 2
“Further, Hanem et al. [9, 31] found increased BMI at both four and eight years of age in children exposed to metformin in utero, which further support metformin’s metabolic effect on the fetus.”
Self-citationThe effects of metformin treatment on the ovaries and uterus of offspring
Ayas, B., Kırmızıkan, S., Kocaman, A., & Avcı, B. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1819002 · Cited by 2
“A recent follow-up study showed that the children exposed to metformin have higher BMI and increased prevalence of obesity [30].”
Backgrounddo Nascimento, I. B., Fleig, R., Silva, R. R. E., & Silva, J. C. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100280 · Cited by 2
Antidiabéticos orais no diabetes gestacional: revisão de literatura
Araújo, P. H. D. A., Gregio, A. C. D. A. R., Scárdua, J. D. L. M., & Trindade, C. R. (2021) · Femina · doi:10.61622/0100-7254493202107 · Cited by 17
Hegerty, C. K., & Ostini, R. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069849 · Cited by 4
Insulin and other hypoglycemic drugs
Schalliol, L. A., Pittman, J. M., & Ray, S. D. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.07.002 · Cited by 4
Comparison of Fetal Outcome in Patients of Gestational Diabetes Treated with Met Formin and Insulin
Sajjad, F., Usman, S., Choudhry, A., Baloch, S. A., Aslam, Q. U. A., & Shahid, G. (2022) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v72isuppl-2.3872 · Cited by 1
Management of Infertility in Overweight or Obese Polycystic Ovary Syndrome Patients
Ruan, X., Yang, Y., Gu, M., & Dhungel, P. (2023) · Reproductive medicine for clinicians · doi:10.1007/978-3-031-24903-7_19 · Cited by 1
Mariot, M. D. M., Kretzer, D. C., Becker, P. C., Nunes, I. M., Goldani, M. Z., Bernardi, J. R., & da Silva, C. H. (2024) · Maternal and Child Nutrition · doi:10.1111/mcn.13656 · Cited by 1
“Children of mothers who used this medication during pregnancy had greater weight and head circumference at 18 months of age (Hjorth ‐ Hansen et al., 2018) and greater risk of overweight/obesity at the age of four (Hanem et al., 2018; Hanem et al., 2019).”
Díez, J. J., Anda, E., Lesmes, I. B., González, C., Miguélez, M., Zugasti, A., & Fernández, A. (2025) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2025.101531 · Cited by 4
Costa, D. N., Malek, R., & Davis, S. N. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2545929 · Cited by 2
Gestational Diabetes Mellitus—A Brief Overview and Current Situation in Romania
Salmen, B.-M., & Bohîlțea, R. E. (2025) · Romanian Journal of Preventive Medicine · doi:10.3390/rjpm3010005 · Cited by 2
Husby, A. E., Simpson, M. R., Dalbye, R., Løvvik, T. S., & Vanky, E. (2026) · International Breastfeeding Journal · doi:10.1186/s13006-026-00843-8 · Cited by 1
“It has no known tera-togenic effects, yet it may affect the long-term metabolic health of the offspring [21].”
Self-citationLodhi, B. M., & Firdous, U. (2021) · BioSight · doi:10.46568/bios.v2i2.35 · Cited by 1
“Metformin has been used as the primary choice for the derangements caused by PCOS [4].”
BackgroundHummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2076-0040 · Cited by 1
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01189-7 · Cited by 1
Fasanella, D. R., Benner, S. L., Tejada, F. R., & Jackson-Ayotunde, P. L. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.08.012 · Cited by 1
Painter, R. C., Finken, M. J. J., & van Rijn, B. B. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.07.006 · Cited by 1
Clinical Application of Metformin Use in Anhui Province, China: A Cross-Sectional Study
Chen, L., Chen, Q., Chen, X., Zhu, P., Chen, M., Wang, W., Ye, S., & Zheng, M. S. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s397061 · Cited by 1
Hipoglucemiantes orales en el control metabólico de la diabetes gestacional.
Lazo-Feijoo, L. A., & Campoverde, L. H. M. (2023) · MQRInvestigar · doi:10.56048/mqr20225.7.3.2023.2454-2482
Hanem, L. G. E., Ødegård, R. A., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01114 · Cited by 1
Self-citationKinder von Schwangeren mit Metformin sind dicker als normal
Stupin, J. H. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1308-2
Castillo-Castro, C., Gonzalez-Velazquez, C. D., & Rodríguez‐Gutiérrez, R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00884
Metformin use in polycystic ovary syndrome pregnancy impacts on offspring obesity
Abbott, D. H. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(19)30001-x
Novosti u liječenju gestacijskog dijabetesa
Hlača, N., & Majanović, S. K. (2019) · Medicina Fluminensis · doi:10.21860/medflum2019_227123
Perinatal nutrition and metabolic disease
Cruz, G., Fernandois, D., Jorquera, G., Llanos, P., Maliqueo, M. A., & Molina, X. E. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813862-5.00009-8
Zoltán, K. I., Kun, I., & Kolcsár, M. (2019) · Orvostudományi Értesítö · doi:10.2478/orvtudert-2019-0016
Koufakis, T., Garas, A., Zebekakis, P. E., & Kotsa, K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1942842
“overweight and obesity at the age of 4 compared with those exposed to placebo [16].”
BackgroundTrout, K. K., & Dolin, C. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818902-3.00005-1
Metformin: childhood anthropometric parameters
(2018) · Reactions Weekly · doi:10.1007/s40278-018-42899-y
Metformin use in PCOS pregnancy: risk of overweight chidren
(2018) · Reactions Weekly · doi:10.1007/s40278-018-42898-y
Lovell, H., Mitchell, A., Ovadia, C., Pitrelli, N., Briley, A. L., Singh, C. M., Marschall, H., Cruickshank, K. J., Murphy, H. R., Seed, P. T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1455906/v1
Chatzakis, C., Sotiriadis, A., Gerede, A., Dinas, K. D., & Nicolaides, K. H. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_16
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2022) · Diabetes aktuell · doi:10.1055/a-1976-8965
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00988-0
“Eine Nachuntersuchung der 4-jährigen Kinder von Frauen mit PCOS unter Metformintherapie in der Schwangerschaft ergab ein deutlich erhöhtes Risiko für Übergewicht/Adipositas im Vergleich zu Placebo [64].”
Ludwig, M. Z. (2023) · gynäkologie + geburtshilfe · doi:10.1007/s15013-023-5140-y
Malkani, N. P., Rosenberg, E. A., & Lassey, S. C. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-34103-8_5
Metformin in pregnancy: everything you always wanted to know but were afraid to ask
Biamonte, E. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.3.4
Agents anti-hyperglycémiants oraux et grossesse
Cosson, E., Pinto, S., Rezgani, I., Barka, I., Sal, M., Zerguine, M., Tatulashvili, S., & Bihan, H. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.01.003
OS EFEITOS DA METFORMINA NO TRATAMENTO DA SÍNDROME DO OVÁRIO POLICÍSTICO
Gonçalves, M. A. R. (2024) · Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida · doi:10.36692/v16n2-125r · Cited by 1
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0352
“Eine Nachuntersuchung der 4-jährigen Kinder von Frauen mit Polyzystischem Ovarialsyn-drom (PCOS) unter Metformintherapie in der Schwangerschaft er-gab ein deutlich erhöhtes Risiko für Übergewicht/Adipositas im Vergleich zu Placebo [64].”
Díez, J. J., Anda, E., Bretón, I., González, C., Miguélez, M., Zugasti, A., & Fernández, A. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.11.001 · Cited by 1
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2499-9780
“A follow-up of 4-year-old children of women with polycystic ovarian syndrome (PCOS) on metformin therapy during pregnancy showed a signifi - cantly increased risk of excess weight/obesity compared with placebo [64].”
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01313-1
Wiles, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-88835-9_7
Gestational Diabetes and Type 2 Diabetes during Pregnancy
Bond, R., & Peters, T. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00050-8
The role of metformin in the treatment of women with metabolic disorders
Urbanovych, A., & Sidelnyk, N. Y. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.7.2025.1644
Lovell, H., Mitchell, A., Ovadia, C., Pitrelli, N., Briley, A., Singh, C. M., Marschall, H., Cruickshank, K. J., Murphy, H. R., Seed, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20342457
Lin, S.-F., Chang, S., Kuo, C.-F., Lin, W.-T., Chiou, M.-J., & Huang, Y.-T. (2020) · Figshare · doi:10.6084/m9.figshare.12922819
Lovell, H., Mitchell, A., Ovadia, C., Pitrelli, N., Briley, A., Singh, C. M., Marschall, H., Cruickshank, K. J., Murphy, H. R., Seed, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20342460
Choudhary, N., & Kriplani, A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010019
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meissner, T., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7979
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01448-9
Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
Bongrani, A. (2022) · theses.fr (ABES) · doi:10.70675/1b281dcdz1f16z4985z95f8z0706a492c996
Scairati, R., Newman, C., Alvarez‐Iglesias, A., Smyth, A., O’Shea, P. M., Devane, D., Gillespie, P., Egan, A. M., O'Donnell, M. J., & Dunne, F. (2026) · Trials · doi:10.1186/s13063-026-09703-6 · Cited by 1
“In pregnancies complicated by polycystic ovary syndrome (PCOS), longitudinal studies have reported higher BMI z-scores and obesity risk in metformin-exposed children at 4 [43] and up to 10 years of age [44].”
Management der Hyperglykämie in der Schwangerschaft (Update 2026)
Kautzky‐Willer, A., Winhofer, Y., Leutner, M., Kiss, H., Falcone, V., Linder, T., Berger, A., Wisgrill, L., Lechleitner, M., Weitgasser, R., et al. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-025-02695-4 · Cited by 1
“Unter einer Therapie mit Metformin bei schwangeren Frauen mit PCOS wurde über eine erhöhte Prävalenz von Übergewicht/Adipositas bei den Kindern im Alter von 4 Jahren berichtet [75].”
Pharmacologic Treatment of Diabetes in Pregnancy
Feghali, M. N. (2026) · Clinics in Perinatology · doi:10.1016/j.clp.2026.04.006
Arenas, G. A., Herrera, E. A., Krause, B. J., Giussani, D. A., Julian, C. G., MOORE, L. G., & Lorca, R. A. (2026) · Physiological Reviews · doi:10.1152/physrev.00003.2026 · Cited by 1
Metformin Exposure in Pregnancy and Fetal Programming: A Focused Review of Contemporary Evidence
Gojnić-Dugalić, M., Dugalić, S., Milinčić, M., & Ivanović, K. (2026) · Biomedicines · doi:10.3390/biomedicines14081867
Metformin use during pregnancy: Current evidence and clinical considerations
Kazakova, T., Zamtikova, M., Zaykov, H., Ivanova, M., & Тодорова, А. (2026) · Scripta Scientifica Medica · doi:10.14748/r6s8n597
“Although some anthropometric indicators of adiposity differ between exposure groups [47], there is no clear or consistent evidence of early cardiometabolic disease, and available data indicate broad similarity across most childhood metabolic measures.”
InfluentialMetabolic homeostasis and women’s reproductive health
Liu, X., 杨利丽, Jiang, J., Chang, H., & Mu, L. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01646-1
Metadata
- Authors
- Hanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E.
- Affiliations
- Norwegian University of Science and Technology (NO)
- University of Bergen (NO)
- KU Leuven (BE)
- Corresponding author
- Hanem, Liv Guro Engen
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-02-27
- Volume
- 103
- Issue
- 4
- Pages
- 1612-1621
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2790276328
- Cited by
- 199
- References
- 41
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 15 · 2023: 21 · 2022: 26 · 2021: 23 · 2020: 23 · 2019: 32 · 2018: 26
- FWCI
- 29.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Norges Forskningsråd (239987)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- metformin, polycystic ovary syndrome, pregnancy, childhood obesity, body mass index, head circumference, maternal-fetal drug transfer, prenatal drug exposure, child growth
- MeSH terms
- Child, Preschool, Double-Blind Method, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Metformin, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, Risk, Body Mass Index, Prevalence, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.